These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9876792)

  • 1. The use of antimicrobials in ten Australian and New Zealand intensive care units. The Australian and New Zealand Intensive Care Multicentre Studies Group Investigators.
    Bellomo R; Bersten AD; Boots RJ; Bristow PJ; Dobb GJ; Finfer SR; McArthur CJ; Richards B; Skowronski GA
    Anaesth Intensive Care; 1998 Dec; 26(6):648-53. PubMed ID: 9876792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units.
    Robertson MS; Nichol AD; Higgins AM; Bailey MJ; Presneill JJ; Cooper DJ; Webb SA; McArthur C; MacIsaac CM; ;
    Crit Care Resusc; 2010 Mar; 12(1):9-15. PubMed ID: 20196708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial utilisation in 37 Australian and New Zealand intensive care units.
    Dulhunty JM; Paterson D; Webb SA; Lipman J
    Anaesth Intensive Care; 2011 Mar; 39(2):231-7. PubMed ID: 21485671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multicenter Evaluation of Prolonged Empiric Antibiotic Therapy in Adult ICUs in the United States.
    Thomas Z; Bandali F; Sankaranarayanan J; Reardon T; Olsen KM;
    Crit Care Med; 2015 Dec; 43(12):2527-34. PubMed ID: 26457751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription of antibiotic agents in Swedish intensive care units is empiric and precise.
    Erlandsson M; Burman LG; Cars O; Gill H; Nilsson LE; Walther SM; Hanberger H;
    Scand J Infect Dis; 2007; 39(1):63-9. PubMed ID: 17366015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of onset and burden of persistent critical illness in Australia and New Zealand: a retrospective, population-based, observational study.
    Iwashyna TJ; Hodgson CL; Pilcher D; Bailey M; van Lint A; Chavan S; Bellomo R
    Lancet Respir Med; 2016 Jul; 4(7):566-573. PubMed ID: 27155770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
    Álvarez-Lerma F; Palomar Martínez M; Olaechea Astigarraga P; Insausti Ordeñana J; López Pueyo MJ; Gracia Arnillas MP; Gimeno Costa R; Seijas Betolaza I
    Rev Esp Quimioter; 2012 Mar; 25(1):65-73. PubMed ID: 22488544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units.
    Montravers P; Dupont H; Gauzit R; Veber B; Bedos JP; Lepape A;
    Crit Care; 2011; 15(1):R17. PubMed ID: 21232098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
    Vasudevan A; Mukhopadhyay A; Li J; Yuen EG; Tambyah PA
    BMC Infect Dis; 2014 Nov; 14():615. PubMed ID: 25420613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium administration in critically ill patients in Australia and New Zealand: a multicentre point prevalence study.
    Bihari S; Peake SL; Seppelt I; Williams P; Bersten A; ;
    Crit Care Resusc; 2013 Dec; 15(4):294-300. PubMed ID: 24289511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality and length-of-stay outcomes, 1993-2003, in the binational Australian and New Zealand intensive care adult patient database.
    Moran JL; Bristow P; Solomon PJ; George C; Hart GK;
    Crit Care Med; 2008 Jan; 36(1):46-61. PubMed ID: 18090383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of antibiotics in the intensive care unit of a tertiary hospital in Malawi.
    Kayambankadzanja RK; Lihaka M; Barratt-Due A; Kachingwe M; Kumwenda W; Lester R; Bilima S; Eriksen J; Baker T
    BMC Infect Dis; 2020 Oct; 20(1):776. PubMed ID: 33076857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study.
    Malacarne P; Rossi C; Bertolini G;
    J Antimicrob Chemother; 2004 Jul; 54(1):221-4. PubMed ID: 15190030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients admitted to Australian intensive care units: impact of remoteness and distance travelled on patient outcome.
    Flabouris A; Hart GK; Nicholls A
    Crit Care Resusc; 2012 Dec; 14(4):256-67. PubMed ID: 23230874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of antibiotic prescribing practices in Australian and New Zealand intensive care units.
    Dulhunty JM; Webb SA; Paterson DL; Bellomo R; Myburgh J; Roberts JA; Lipman J
    Crit Care Resusc; 2010 Sep; 12(3):162-70. PubMed ID: 21261573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of antibiotic usage in the intensive care unit at the University Hospital of the West Indies.
    Chin V; Harding HE; Tennant I; Soogrim D; Gordon-Strachan GM; Frankson MA
    West Indian Med J; 2010 Mar; 59(2):159-64. PubMed ID: 21275119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit.
    Najafi A; Khodadadian A; Sanatkar M; Shariat Moharari R; Etezadi F; Ahmadi A; Imani F; Khajavi MR
    Acta Med Iran; 2015; 53(9):562-7. PubMed ID: 26553084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk prediction of hospital mortality for adult patients admitted to Australian and New Zealand intensive care units: development and validation of the Australian and New Zealand Risk of Death model.
    Paul E; Bailey M; Pilcher D
    J Crit Care; 2013 Dec; 28(6):935-41. PubMed ID: 24074958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.